A new study by Keck School of Medicine (KSOM) researchers reveals how therapies targeting a molecular chaperone called GRP78 might offer additional protection against COVID-19 and other coronaviruses that emerge in the future.
Just last year, this sampler was used to better understand the spread of COVID-19, an unexpected but logical adaption, Sioutas said. “COVID-19 is nothing more than an aerosol,” he said. “We can look at it the same way as all other particulate air pollutants.”
The Stevens Center has partnered with leading universities worldwide and created a humanitarian use express license agreement to accelerate the transfer and development of COVID-19 discoveries.